[Skip to Navigation]
Article
September 1933

"SPECIFIC TREATMENT OF OPHTHALMIC TUBERCULOSIS WITH A NEW TUBERCULOSIS ANTIGEN `AO'"

Author Affiliations

Osaka, Japan.

Arch Ophthalmol. 1933;10(3):423. doi:10.1001/archopht.1933.00830040141014

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.

Abstract

To the Editor:—The following inquiries have been received pertaining to my paper, entitled, "Specific Treatment of Ophthalmic Tuberculosis with a New Tuberculosis Antigen `A O,' " in the August issue of the Archives, page 161. As ophthalmologists in general may be interested in them, I am sending the answers for publication:

  1. Where is A O to be obtained? It can be obtained at Arimakenkiujo Ebie Nishinariku, Osaka, Japan.

  2. When you are using a single optimal dose, do you always give it at four day intervals, and for how long a period?

  3. For fifteen years I have been using only the optimal dose, but during the past year I have used A O, no. 1, 1 cc. for the optimal dose, for adults, every eight days.

  4. What method have you found the best for diagnosis, the subcutaneous reaction to tuberculin or the Mantoux intradermal test? Patients are

First Page Preview View Large
First page PDF preview
First page PDF preview
Add or change institution
×